BARD C R INC /NJ/ (BCR)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $4.7M
- Dec 20 · Unusual
- Form 4 sales
- 454
- On record
- Form 144 notices
- 0
- Proposed sales
- Sold, last 30 days
- None
- No Form 4 sale
- Sold, last 90 days
- None
- No Form 4 sale
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- Dec 20, 2017Unusual
John A DeFord, Sr. VP Sci Tech and Clin Afrs, sold 45.7% of their holdings
$4.7M14,107 shares at $333.47
- Dec 14, 2017Plan not stated
Jim C Beasley, Group President, sold 13.2% of their holdings
$1.1M3,395 shares at $332.00
- Dec 11, 2017Unusual
Jim C Beasley, Group President, sold 40.4% of their holdings
$5M15,044 shares at $332.00
- Nov 7, 2017Unusual
John H Weiland, Vice Chairman, Pres. and COO, sold 43.8% of their holdings
$11.1M33,435 shares at $333.31
- Nov 2, 2017Unusual
Frank Lupisella Jr, Vice President and Controller, sold 42% of their holdings
$2.4M7,035 shares at $334.70
- Nov 2, 2017Unusual
Christopher S Holland, Senior Vice President and CFO, sold 58.6% of their holdings
$12.8M38,242 shares at $334.04
- Oct 30, 2017Unusual
David M Barrett, Director, sold 67.5% of their holdings
$1.1M3,344 shares at $327.31
- Oct 20, 2017Unusual
Betty D Larson, VP - Human Resources, sold 41.3% of their holdings
$1.9M5,906 shares at $330.16
- Oct 18, 2017Unusual
Frank Lupisella Jr, Vice President and Controller, sold 47.4% of their holdings
$3M9,173 shares at $325.00
- Oct 12, 2017Unusual
Timothy P Collins, Group President, sold 67.7% of their holdings
$18M55,818 shares at $322.03
Every transaction
| Traded | Filed | Stock | Name | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 29, 2017 | Jan 3, 2018 | BCR | Sharon M Luboff | Group Vice President | Returned to the companyOption (Right to Buy) | 90,614 | 0 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | Sharon M Luboff | Group Vice President | Returned to the company | 36,765 | 0 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | Sharon M Luboff | Group Vice President | Awarded | 15,872 | 36,696 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | Samrat S. Khichi | Sr. VP, Gen Counsel & Secy. | Returned to the companyOption (Right to Buy) | 34,998 | 0 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | Samrat S. Khichi | Sr. VP, Gen Counsel & Secy. | Returned to the company | 28,813 | 0 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | Samrat S. Khichi | Sr. VP, Gen Counsel & Secy. | Awarded | 12,425 | 28,813 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | John P Groetelaars | Group President | Returned to the companyOption (Right to Buy) | 46,734 | 0 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | John P Groetelaars | Group President | Returned to the company | 39,448 | 0 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | John P Groetelaars | Group President | Awarded | 20,485 | 39,448 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | John A DeFord | Sr. VP Sci Tech and Clin Afrs | Returned to the companyOption (Right to Buy) | 19,012 | 0 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | John A DeFord | Sr. VP Sci Tech and Clin Afrs | Returned to the company | 36,066 | 0 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | John A DeFord | Sr. VP Sci Tech and Clin Afrs | Awarded | 19,193 | 35,982 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | Timothy P Collins | Group President | Returned to the companyOption (Right to Buy) | 42,116 | 0 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | Timothy P Collins | Group President | Returned to the company | 51,168 | 0 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | Timothy P Collins | Group President | Awarded | 24,166 | 50,812 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | Christopher S Holland | Senior Vice President and CFO | Returned to the companyOption (Right to Buy) | 57,622 | 0 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | Christopher S Holland | Senior Vice President and CFO | Returned to the company | 51,912 | 0 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | Christopher S Holland | Senior Vice President and CFO | Awarded | 24,921 | 51,912 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | John H Weiland | Vice Chairman, Pres. and COO | Returned to the companyOption (Right to Buy) | 96,110 | 0 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | John H Weiland | Vice Chairman, Pres. and COO | Returned to the company | 89,996 | 0 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | John H Weiland | Vice Chairman, Pres. and COO | Awarded | 41,081 | 83,977 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | Timothy M Ring | Chairman and CEO | Returned to the companyOption (Right to Buy) | 317,445 | 0 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | Timothy M Ring | Chairman and CEO | Returned to the company | 158,182 | 0 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | Timothy M Ring | Chairman and CEO | Awarded | 85,953 | 153,451 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | Gerard D Porreca III | VP, Quality, Reg & Med Affairs | Returned to the companyOption (Right to Buy) | 9,441 | 0 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | Gerard D Porreca III | VP, Quality, Reg & Med Affairs | Returned to the company | 5,166 | 0 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | Gerard D Porreca III | VP, Quality, Reg & Med Affairs | Awarded | 2,497 | 5,166 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | Frank Lupisella Jr | Vice President and Controller | Returned to the companyOption (Right to Buy) | 9,085 | 0 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | Frank Lupisella Jr | Vice President and Controller | Returned to the company | 13,089 | 0 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | Frank Lupisella Jr | Vice President and Controller | Awarded | 3,755 | 13,089 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | Betty D Larson | VP - Human Resources | Returned to the companyOption (Right to Buy) | 15,093 | 0 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | Betty D Larson | VP - Human Resources | Returned to the company | 13,454 | 0 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | Betty D Larson | VP - Human Resources | Awarded | 5,502 | 13,454 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | Jim C Beasley | Group President | Returned to the companyOption (Right to Buy) | 23,677 | 0 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | Jim C Beasley | Group President | Returned to the company | 46,401 | 0 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | Jim C Beasley | Group President | Awarded | 24,166 | 46,401 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | Robert M Davis | Director | Returned to the companyShare Equivalent Units | 1,062 | 0 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | Robert M Davis | Director | Returned to the company | 1,302 | 0 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | David M Barrett | Director | Returned to the companyPhantom Stock Units | 8,992 | 0 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | David M Barrett | Director | Returned to the company | 1,910 | 0 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | David M Barrett | Director | AwardedPhantom Stock Units | 82 | $331.24 | $27k | 3,818 | SEC |
| Dec 29, 2017 | Jan 3, 2018 | BCR | Herbert L Henkel | Director | Returned to the companyPhantom Stock Units | 30,391 | 0 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | Herbert L Henkel | Director | Returned to the company | 11,787 | 0 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | John C. Kelly | Director | Returned to the companyOption (Right to Buy) | 11,717 | 0 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | John C. Kelly | Director | Returned to the company | 6,579 | 0 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | John C. Kelly | Director | AwardedPhantom Stock Units | 116 | $331.24 | $38k | 5,343 | SEC |
| Dec 29, 2017 | Jan 3, 2018 | BCR | David F Melcher | Director | Returned to the companyShare Equivalent Units | 1,475 | 0 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | David F Melcher | Director | Returned to the company | 2,407 | 0 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | Gail K Naughton | Director | Returned to the companyShare Equivalent Units | 9,516 | 0 | SEC | ||
| Dec 29, 2017 | Jan 3, 2018 | BCR | Gail K Naughton | Director | Returned to the company | 1,923 | 0 | SEC |
Sales, notices and lockups (newest 400 of 454)
Export watchlist as CSV| Source | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 20, 2017 | Dec 22, 2017 | John A DeFord | BCR | Sr. VP Sci Tech and Clin Afrs | Form 4 sale | 14,107 | $4.7M | 45.7% | Unusual | SEC |
| Dec 14, 2017 | Dec 18, 2017 | Jim C Beasley | BCR | Group President | Form 4 sale | 3,395 | $1.1M | 13.2% | Plan not stated | SEC |
| Dec 11, 2017 | Dec 13, 2017 | Jim C Beasley | BCR | Group President | Form 4 sale | 15,044 | $5M | 40.4% | Unusual | SEC |
| Nov 7, 2017 | Nov 9, 2017 | John H Weiland | BCR | Vice Chairman, Pres. and COO | Form 4 sale | 33,435 | $11.1M | 43.8% | Unusual | SEC |
| Nov 2, 2017 | Nov 6, 2017 | Frank Lupisella Jr | BCR | Vice President and Controller | Form 4 sale | 7,035 | $2.4M | 42.0% | Unusual | SEC |
| Nov 2, 2017 | Nov 6, 2017 | Christopher S Holland | BCR | Senior Vice President and CFO | Form 4 sale | 38,242 | $12.8M | 58.6% | Unusual | SEC |
| Oct 30, 2017 | Oct 31, 2017 | David M Barrett | BCR | Director | Form 4 sale | 3,344 | $1.1M | 67.5% | Unusual | SEC |
| Oct 20, 2017 | Oct 24, 2017 | Betty D Larson | BCR | VP - Human Resources | Form 4 sale | 5,906 | $1.9M | 41.3% | Unusual | SEC |
| Oct 18, 2017 | Oct 20, 2017 | Frank Lupisella Jr | BCR | Vice President and Controller | Form 4 sale | 9,173 | $3M | 47.4% | Unusual | SEC |
| Oct 12, 2017 | Oct 16, 2017 | Timothy P Collins | BCR | Group President | Form 4 sale | 55,818 | $18M | 67.7% | Unusual | SEC |
| Oct 9, 2017 | Oct 10, 2017 | Timothy P Collins | BCR | Group President | Form 4 sale | 8,388 | $2.7M | 23.9% | Plan not stated | SEC |
| Sep 29, 2017 | Oct 2, 2017 | Sharon M Luboff | BCR | Group Vice President | Form 4 sale | 30,252 | $9.7M | 59.2% | Unusual | SEC |
| Aug 10, 2017 | Aug 11, 2017 | John P Groetelaars | BCR | Group President | Form 4 sale | 23,687 | $7.5M | 55.5% | Unusual | SEC |
| Apr 24, 2017 | Apr 25, 2017 | Frank Lupisella Jr | BCR | Vice President and Controller | Form 4 sale | 3,622 | $1.1M | 26.3% | Unusual | SEC |
| Feb 21, 2017 | Feb 22, 2017 | Jim C Beasley | BCR | Group President | Form 4 sale | 4,390 | $1.1M | 16.5% | Plan not stated | SEC |
| Feb 14, 2017 | Feb 15, 2017 | Christopher S Holland | BCR | Senior Vice President and CFO | Form 4 sale | 618 | $149k | 2.2% | Plan not stated | SEC |
| Feb 14, 2017 | Feb 15, 2017 | Sharon M Luboff | BCR | Group Vice President | Form 4 sale | 3,659 | $880k | 15.0% | Plan not stated | SEC |
| Feb 14, 2017 | Feb 15, 2017 | Jim C Beasley | BCR | Group President | Form 4 sale | 3,213 | $773k | 12.6% | Plan not stated | SEC |
| Feb 14, 2017 | Feb 15, 2017 | John A DeFord | BCR | Sr. VP Sci Tech and Clin Afrs | Form 4 sale | 2,788 | $671k | 12.5% | Plan not stated | SEC |
| Feb 14, 2017 | Feb 15, 2017 | Timothy P Collins | BCR | Group President | Form 4 sale | 3,768 | $906k | 12.4% | Plan not stated | SEC |
| Feb 14, 2017 | Feb 15, 2017 | John P Groetelaars | BCR | Group President | Form 4 sale | 732 | $176k | 3.7% | Plan not stated | SEC |
| Feb 14, 2017 | Feb 15, 2017 | Timothy M Ring | BCR | Chairman and CEO | Form 4 sale | 14,425 | $3.5M | 16.3% | Plan not stated | SEC |
| Feb 14, 2017 | Feb 15, 2017 | John H Weiland | BCR | Vice Chairman, Pres. and COO | Form 4 sale | 14,091 | $3.4M | 24.7% | Plan not stated | SEC |
| Feb 13, 2017 | Feb 14, 2017 | Sharon M Luboff | BCR | Group Vice President | Form 4 sale | 1,478 | $355k | 5.1% | Plan not stated | SEC |
| Feb 13, 2017 | Feb 14, 2017 | Jim C Beasley | BCR | Group President | Form 4 sale | 734 | $176k | 2.6% | Plan not stated | SEC |
| Feb 13, 2017 | Feb 14, 2017 | John A DeFord | BCR | Sr. VP Sci Tech and Clin Afrs | Form 4 sale | 469 | $113k | 1.9% | Plan not stated | SEC |
| Feb 13, 2017 | Feb 14, 2017 | John P Groetelaars | BCR | Group President | Form 4 sale | 450 | $108k | 2.2% | Plan not stated | SEC |
| Feb 13, 2017 | Feb 14, 2017 | Christopher S Holland | BCR | Senior Vice President and CFO | Form 4 sale | 642 | $154k | 2.2% | Plan not stated | SEC |
| Feb 13, 2017 | Feb 14, 2017 | Timothy M Ring | BCR | Chairman and CEO | Form 4 sale | 1,767 | $424k | 1.7% | Plan not stated | SEC |
| Feb 13, 2017 | Feb 14, 2017 | Timothy P Collins | BCR | Group President | Form 4 sale | 642 | $154k | 1.9% | Plan not stated | SEC |
| Feb 13, 2017 | Feb 14, 2017 | John H Weiland | BCR | Vice Chairman, Pres. and COO | Form 4 sale | 1,274 | $306k | 1.8% | Plan not stated | SEC |
| Feb 10, 2017 | Feb 13, 2017 | Betty D Larson | BCR | VP - Human Resources | Form 4 sale | 3,292 | $793k | 28.2% | Unusual | SEC |
| Feb 9, 2017 | Feb 10, 2017 | Samrat S. Khichi | BCR | Sr. VP, Gen Counsel & Secy. | Form 4 sale | 5,827 | $1.4M | 26.3% | Unusual | SEC |
| Feb 9, 2017 | Feb 10, 2017 | John P Groetelaars | BCR | Group President | Form 4 sale | 5,504 | $1.3M | 20.6% | Plan not stated | SEC |
| Feb 9, 2017 | Feb 10, 2017 | John A DeFord | BCR | Sr. VP Sci Tech and Clin Afrs | Form 4 sale | 5,816 | $1.4M | 18.5% | Plan not stated | SEC |
| Feb 9, 2017 | Feb 10, 2017 | Timothy P Collins | BCR | Group President | Form 4 sale | 7,602 | $1.8M | 17.8% | Plan not stated | SEC |
| Feb 9, 2017 | Feb 10, 2017 | Sharon M Luboff | BCR | Group Vice President | Form 4 sale | 5,801 | $1.4M | 17.1% | Plan not stated | SEC |
| Feb 9, 2017 | Feb 10, 2017 | Timothy M Ring | BCR | Chairman and CEO | Form 4 sale | 20,324 | $4.9M | 16.1% | Plan not stated | SEC |
| Feb 9, 2017 | Feb 10, 2017 | Christopher S Holland | BCR | Senior Vice President and CFO | Form 4 sale | 7,597 | $1.8M | 20.5% | Plan not stated | SEC |
| Feb 9, 2017 | Feb 10, 2017 | Jim C Beasley | BCR | Group President | Form 4 sale | 8,593 | $2.1M | 22.9% | Plan not stated | SEC |
| Feb 9, 2017 | Feb 10, 2017 | John H Weiland | BCR | Vice Chairman, Pres. and COO | Form 4 sale | 14,281 | $3.4M | 16.7% | Plan not stated | SEC |
| Jan 31, 2017 | Feb 1, 2017 | Gail K Naughton | BCR | Director | Form 4 sale | 367 | $87k | 18.5% | Plan not stated | SEC |
| Jan 11, 2017 | Jan 12, 2017 | John P Groetelaars | BCR | Group President | Form 4 sale | 573 | $135k | 3.3% | Plan not stated | SEC |
| Jan 10, 2017 | Jan 11, 2017 | Frank Lupisella Jr | BCR | Vice President and Controller | Form 4 sale | 2,945 | $683k | 20.2% | Plan not stated | SEC |
| Dec 30, 2016 | Jan 3, 2017 | Jim C Beasley | BCR | Group President | Form 4 sale | 4,709 | $1.1M | 17.2% | Plan not stated | SEC |
| Dec 30, 2016 | Jan 3, 2017 | Frank Lupisella Jr | BCR | Vice President and Controller | Form 4 sale | 237 | $54k | 1.6% | Plan not stated | SEC |
| Dec 12, 2016 | Dec 14, 2016 | Jim C Beasley | BCR | Group President | Form 4 sale | 11,922 | $2.6M | 34.5% | Unusual | SEC |
| Dec 12, 2016 | Dec 14, 2016 | John H Weiland | BCR | Vice Chairman, Pres. and COO | Form 4 sale | 11,190 | $2.5M | 15.4% | Plan not stated | SEC |
| Dec 12, 2016 | Dec 14, 2016 | Sharon M Luboff | BCR | Group Vice President | Form 4 sale | 6,000 | $1.3M | 20.1% | Plan not stated | SEC |
| Dec 12, 2016 | Dec 13, 2016 | John A DeFord | BCR | Sr. VP Sci Tech and Clin Afrs | Form 4 sale | 15,883 | $3.5M | 42.4% | Unusual | SEC |